211 related articles for article (PubMed ID: 21408181)
1. Performance deficits of NK1 receptor knockout mice in the 5-choice serial reaction-time task: effects of d-amphetamine, stress and time of day.
Yan TC; Dudley JA; Weir RK; Grabowska EM; Peña-Oliver Y; Ripley TL; Hunt SP; Stephens DN; Stanford SC
PLoS One; 2011 Mar; 6(3):e17586. PubMed ID: 21408181
[TBL] [Abstract][Full Text] [Related]
2. The influence of test experience and NK1 receptor antagonists on the performance of NK1R-/- and wild type mice in the 5-Choice Serial Reaction-Time Task.
Weir RK; Dudley JA; Yan TC; Grabowska EM; Peña-Oliver Y; Ripley TL; Stephens DN; Stanford SC; Hunt SP
J Psychopharmacol; 2014 Mar; 28(3):270-81. PubMed ID: 23845920
[TBL] [Abstract][Full Text] [Related]
3. Antagonism of L-type Ca(v) channels with nifedipine differentially affects performance of wildtype and NK1R-/- mice in the 5-Choice Serial Reaction-Time Task.
Dudley JA; Weir RK; Yan TC; Grabowska EM; Grimmé AJ; Amini S; Stephens DN; Hunt SP; Stanford SC
Neuropharmacology; 2013 Jan; 64():329-36. PubMed ID: 22884624
[TBL] [Abstract][Full Text] [Related]
4. Differences in the performance of NK1R-/- ('knockout') and wildtype mice in the 5‑Choice Continuous Performance Test.
Porter AJ; Pillidge K; Stanford SC; Young JW
Behav Brain Res; 2016 Feb; 298(Pt B):268-77. PubMed ID: 26522842
[TBL] [Abstract][Full Text] [Related]
5. Perseveration by NK1R-/- ('knockout') mice is blunted by doses of methylphenidate that affect neither other aspects of their cognitive performance nor the behaviour of wild-type mice in the 5-Choice Continuous Performance Test.
Pillidge K; Porter AJ; Young JW; Stanford SC
J Psychopharmacol; 2016 Sep; 30(9):837-47. PubMed ID: 27097734
[TBL] [Abstract][Full Text] [Related]
6. A lack of functional NK1 receptors explains most, but not all, abnormal behaviours of NK1R-/- mice(1).
Porter AJ; Pillidge K; Tsai YC; Dudley JA; Hunt SP; Peirson SN; Brown LA; Stanford SC
Genes Brain Behav; 2015 Feb; 14(2):189-99. PubMed ID: 25558794
[TBL] [Abstract][Full Text] [Related]
7. The angiotensin converting enzyme inhibitor, captopril, prevents the hyperactivity and impulsivity of neurokinin-1 receptor gene 'knockout' mice: sex differences and implications for the treatment of attention deficit hyperactivity disorder.
Porter AJ; Pillidge K; Grabowska EM; Stanford SC
Eur Neuropsychopharmacol; 2015 Apr; 25(4):512-21. PubMed ID: 25703442
[TBL] [Abstract][Full Text] [Related]
8. Behavioural and neurochemical abnormalities in mice lacking functional tachykinin-1 (NK1) receptors: a model of attention deficit hyperactivity disorder.
Yan TC; Hunt SP; Stanford SC
Neuropharmacology; 2009 Dec; 57(7-8):627-35. PubMed ID: 19748515
[TBL] [Abstract][Full Text] [Related]
9. NK1 (TACR1) receptor gene 'knockout' mouse phenotype predicts genetic association with ADHD.
Yan TC; McQuillin A; Thapar A; Asherson P; Hunt SP; Stanford SC; Gurling H
J Psychopharmacol; 2010 Jan; 24(1):27-38. PubMed ID: 19204064
[TBL] [Abstract][Full Text] [Related]
10. Atomoxetine reduces hyperactive/impulsive behaviours in neurokinin-1 receptor 'knockout' mice.
Pillidge K; Porter AJ; Vasili T; Heal DJ; Stanford SC
Pharmacol Biochem Behav; 2014 Dec; 127():56-61. PubMed ID: 25450119
[TBL] [Abstract][Full Text] [Related]
11. The NK1R-/- mouse phenotype suggests that small body size, with a sex- and diet-dependent excess in body mass and fat, are physical biomarkers for a human endophenotype with vulnerability to attention deficit hyperactivity disorder.
Pillidge K; Heal DJ; Stanford SC
J Psychopharmacol; 2016 Sep; 30(9):848-55. PubMed ID: 27462087
[TBL] [Abstract][Full Text] [Related]
12. The behavioural response of mice lacking NK₁ receptors to guanfacine resembles its clinical profile in treatment of ADHD.
Pillidge K; Porter AJ; Dudley JA; Tsai YC; Heal DJ; Stanford SC
Br J Pharmacol; 2014 Oct; 171(20):4785-96. PubMed ID: 25074741
[TBL] [Abstract][Full Text] [Related]
13. Influence of intertrial interval on basal and drug-induced impulsive action in the 5-choice serial reaction time task: Effects of d-amphetamine and (±)-2,5-dimethoxy-4-iodoamphetamine (DOI).
Fitzpatrick CM; Maric VS; Bate ST; Andreasen JT
Neurosci Lett; 2018 Jan; 662():351-355. PubMed ID: 29102783
[TBL] [Abstract][Full Text] [Related]
14. Effects of amphetamine and methylphenidate on attentional performance and impulsivity in the mouse 5-Choice Serial Reaction Time Task.
Caballero-Puntiverio M; Fitzpatrick CM; Woldbye DP; Andreasen JT
J Psychopharmacol; 2017 Feb; 31(2):272-283. PubMed ID: 28093027
[TBL] [Abstract][Full Text] [Related]
15. Raised arterial blood pressure in neurokinin-1 receptor-deficient mice (NK1R(-/-) ): evidence for a neural rather than a vascular mechanism.
Moyes AJ; Stanford SC; Hosford PS; Hobbs AJ; Ramage AG
Exp Physiol; 2016 May; 101(5):588-98. PubMed ID: 26876733
[TBL] [Abstract][Full Text] [Related]
16. Sub-optimal performance in the 5-choice serial reaction time task in rats was sensitive to methylphenidate, atomoxetine and d-amphetamine, but unaffected by the COMT inhibitor tolcapone.
Paterson NE; Ricciardi J; Wetzler C; Hanania T
Neurosci Res; 2011 Jan; 69(1):41-50. PubMed ID: 20934466
[TBL] [Abstract][Full Text] [Related]
17. 'Waiting impulsivity' in isolation-reared and socially-reared rats: effects of amphetamine.
Liu YP; Wilkinson LS; Robbins TW
Psychopharmacology (Berl); 2017 May; 234(9-10):1587-1601. PubMed ID: 28314950
[TBL] [Abstract][Full Text] [Related]
18. Differential effects of ADHD medications on impulsive action in the mouse 5-choice serial reaction time task.
Fitzpatrick CM; Andreasen JT
Eur J Pharmacol; 2019 Mar; 847():123-129. PubMed ID: 30690006
[TBL] [Abstract][Full Text] [Related]
19. Cognitive sequelae of intravenous amphetamine self-administration in rats: evidence for selective effects on attentional performance.
Dalley JW; Theobald DE; Berry D; Milstein JA; Lääne K; Everitt BJ; Robbins TW
Neuropsychopharmacology; 2005 Mar; 30(3):525-37. PubMed ID: 15508024
[TBL] [Abstract][Full Text] [Related]
20. Disruption of noradrenergic transmission and the behavioural response to a novel environment in NK1R-/- mice.
Fisher AS; Stewart RJ; Yan T; Hunt SP; Stanford SC
Eur J Neurosci; 2007 Feb; 25(4):1195-204. PubMed ID: 17331215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
